Lou and Jean Malnati Brain Tumor Institute of Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital offers comprehensive, leading-edge care for patients with primary or metastatic tumors of the brain or spine. Our scientists have pioneered therapies and developed better standards of care. They specialize in rare and challenging tumors, including:
We are proud to be one of the first institutions in the world to use DNA methylation profiling to diagnose brain tumors. Our world-class team includes thought leaders and faculty from a wide range of disciplines, including Roger Stupp, MD, Matt Lesniak, MD, Jean-Paul Wolinsky, MD, and Amy Heimberger, MD from the departments of Neurology and Neurosurgery. We also have a renowned neuropathology program led by Daniel Brat, MD, and Craig Horbinski, MD, PhD. Refer a PatientNorthwestern Medicine Malnati Brain Tumor Institute welcomes the opportunity to collaborate with you on the care of your patients. To refer a patient, call 833.88.BRAIN (833.882.7246).
|
Meet the Malnati Brain Tumor Institute TeamOur team includes experts who specialize in virtually every type of brain tumor, including rare and complex tumors. We welcome the opportunity to collaborate with you on the care of your patients. Ranked in the Top 10 in the Nation for Neurology and Neurosurgery, and Cancer**Northwestern Memorial Hospital by U.S. News & World Report, 2022 – 23 |
Northwestern Medicine scientists have discovered a new biomarker to identify which patients with brain tumors called glioblastomas might benefit from immunotherapy. The treatment could extend survival for an estimated 20 - 30% of patients.
|
Northwestern Medicine is now one of few institutions worldwide to offer methylation profiling for brain tumors. Northwestern Medicine’s Craig M. Horbinski, MD, PhD, Lawrence J. Jennings, MD, PhD, and Lucas Santana dos Santos, PhD, join the latest episode of the Better Edge podcast to discuss the details of this groundbreaking diagnostic tool.
|
Jessica W. Templer, MD, assistant professor of Neurology (Epilepsy/Clinical Neurophysiology) at Northwestern Medicine, discusses the approach to patients with epilepsy secondary to a suspected low grade glioma and patient selection for intraoperative ECoG and awake craniotomies.
|
About Us Terms of Use Privacy Policy
© 2023 Northwestern Medicine® and Northwestern Memorial HealthCare. Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University |
Connect with us
breakthroughsforphysicians@nm.org International physicians, contact international@nm.org |